Emerging Business Models and Strategies to Accelerate Innovation in the Biopharmaceutical Industry.
- Published in:
- Journal of Commercial Biotechnology, 2016, v. 22, n. 4, p. 53, doi. 10.5912/jcb753
- By:
- Publication type:
- Article
Works matching IS 14628732 AND DT 2016 AND VI 22 AND IP 4
Results: 5
1
2
Biotech Venture Capital Investments in Public Equities and Performance.
- Published in:
- Journal of Commercial Biotechnology, 2016, v. 22, n. 4, p. 39, doi. 10.5912/jcb758
- By:
- Publication type:
- Article
3
Leaving Money on the Table in Venture-Backed biotechnology IPOs.
- Published in:
- Journal of Commercial Biotechnology, 2016, v. 22, n. 4, p. 27, doi. 10.5912/jcb757
- By:
- Publication type:
- Article
4
Induced Pluripotent Stem Cells: Inventors turning into competitors. Can a competitive patent combat yield better inventions in stem cell research?
- Published in:
- Journal of Commercial Biotechnology, 2016, v. 22, n. 4, p. 19, doi. 10.5912/jcb756
- By:
- Publication type:
- Article
5
Do Venture Capital Firms Play as Supportive Mentors or Free-riders? Evidence from China.
- Published in:
- Journal of Commercial Biotechnology, 2016, v. 22, n. 4, p. 3
- By:
- Publication type:
- Article